Eugene Braunwald Selected Research

Pravastatin (Pravachol)

6/2011	Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome.
12/2009	Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
9/2008	Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
9/2008	Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
3/2008	Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy.
2/2008	Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.
1/2008	Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.
1/2008	Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.
1/2008	Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial.
10/2007	Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eugene Braunwald Research Topics

Disease

264	Myocardial Infarction 10/2022 - 02/2002
173	Acute Coronary Syndrome 01/2022 - 02/2002
118	Stroke (Strokes) 09/2022 - 04/2004
112	Hemorrhage 09/2022 - 02/2002
104	Heart Failure 01/2022 - 03/2002
64	ST Elevation Myocardial Infarction 01/2022 - 03/2002
52	Atrial Fibrillation 09/2022 - 09/2010
44	Thrombosis (Thrombus) 01/2021 - 07/2002
34	Ischemia 10/2018 - 07/2003
33	Diabetes Mellitus 11/2021 - 10/2002
29	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 11/2002
29	Unstable Angina 02/2016 - 02/2002
23	Ischemic Stroke 11/2020 - 09/2009
20	Coronary Disease (Coronary Heart Disease) 01/2018 - 03/2002
19	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 04/2002
19	Infections 04/2018 - 04/2002
17	Embolism (Embolus) 09/2022 - 10/2010
17	Atherosclerosis 03/2022 - 02/2003
17	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2021 - 04/2003
17	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2011
16	Hypertension (High Blood Pressure) 01/2021 - 02/2003
16	Infarction (Infarctions) 10/2016 - 04/2002
15	Peripheral Arterial Disease 09/2022 - 08/2004
14	Non-ST Elevated Myocardial Infarction 08/2014 - 02/2002
10	Transient Ischemic Attack 11/2020 - 10/2011
9	Body Weight (Weight, Body) 01/2022 - 03/2005
9	Fibrosis (Cirrhosis) 01/2021 - 01/2012
9	Vascular Diseases (Vascular Disease) 07/2019 - 04/2003
9	Inflammation (Inflammations) 04/2018 - 02/2003
9	Myocardial Ischemia (Ischemic Heart Diseases) 10/2017 - 07/2002
8	Hemorrhagic Stroke 01/2021 - 08/2014
6	Neoplasms (Cancer) 01/2022 - 05/2002
6	Chronic Renal Insufficiency 01/2021 - 12/2004
6	Necrosis 03/2019 - 05/2005
6	Renal Insufficiency (Renal Failure) 02/2019 - 02/2003
6	Thromboembolism 01/2019 - 09/2010

Drug/Important Bio-Agent (IBA)

47	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2002
44	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 09/2010
41	edoxabanIBA 09/2022 - 10/2010
39	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 04/2004
39	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 09/2002
36	Clopidogrel (Plavix)FDA Link 01/2020 - 08/2004
31	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021 - 02/2002
30	Factor Xa (Coagulation Factor Xa)IBA 04/2021 - 10/2010
28	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2005
27	Glycoproteins (Glycoprotein)IBA 01/2018 - 11/2002
27	Pravastatin (Pravachol)FDA LinkGeneric 06/2011 - 03/2002
25	Atorvastatin (Lipitor)FDA Link 07/2019 - 04/2002
23	Heparin (Liquaemin)FDA LinkGeneric 09/2010 - 02/2002
22	Simvastatin (Zocor)FDA LinkGeneric 10/2021 - 09/2004
22	TicagrelorIBA 01/2021 - 04/2014
22	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 04/2002
21	C-Reactive ProteinIBA 01/2019 - 04/2002
21	Tirofiban (Aggrastat)FDA Link 09/2008 - 07/2002
20	Ezetimibe (Zetia)FDA Link 10/2021 - 08/2014
20	AnticoagulantsIBA 02/2021 - 03/2005
20	Troponin IIBA 12/2018 - 04/2002
19	vorapaxarIBA 01/2018 - 09/2009
18	saxagliptin FDA Link 11/2021 - 11/2011
17	LipidsIBA 03/2022 - 04/2003
16	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 03/2015
16	Neurofibromin 2 (Merlin)IBA 10/2015 - 06/2006
16	Ranolazine FDA Link 01/2015 - 06/2006
15	LDL CholesterolIBA 11/2020 - 03/2002
15	TroponinIBA 11/2020 - 09/2003
14	oxidized low density lipoproteinIBA 03/2022 - 03/2002
14	Pharmaceutical PreparationsIBA 11/2020 - 02/2002
13	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 07/2007
13	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2006
12	CreatinineIBA 01/2022 - 11/2003
12	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 11/2004
12	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 10/2021 - 11/2008
12	RivaroxabanIBA 03/2019 - 05/2011
11	Factor Xa InhibitorsIBA 03/2019 - 10/2010
11	Eptifibatide (Integrilin)FDA Link 04/2014 - 04/2003
10	Troponin T (Troponin T1)IBA 11/2021 - 09/2002
10	Vitamin K FDA Link 01/2021 - 10/2010
10	Enalapril FDA LinkGeneric 01/2021 - 01/2018
10	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2014 - 11/2004
10	N(2)-(3-trifluoromethylphenyl)guanineIBA 04/2014 - 04/2002
9	omega-Chloroacetophenone (Mace)IBA 01/2020 - 06/2006
9	DiureticsIBA 12/2018 - 03/2011
9	Thrombin Receptors (Thrombin Receptor)IBA 01/2018 - 12/2014
9	Natriuretic PeptidesIBA 01/2018 - 11/2004
9	AntithrombinsIBA 08/2011 - 04/2002
8	thienopyridineIBA 01/2016 - 11/2007
7	Neprilysin (Neutral Endopeptidase)IBA 10/2022 - 03/2015
7	Valsartan (Vals)FDA Link 01/2022 - 08/2010
7	darapladibIBA 01/2021 - 10/2011
7	trandolapril (Mavik)FDA LinkGeneric 01/2019 - 11/2004
7	Tenecteplase FDA Link 07/2005 - 04/2003
6	Thrombin FDA Link 03/2019 - 06/2006
6	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2018 - 04/2006

Therapy/Procedure

167	Therapeutics 03/2022 - 03/2002
46	Percutaneous Coronary Intervention 12/2021 - 04/2002
25	Stents 12/2021 - 11/2007
21	Thrombolytic Therapy 01/2021 - 10/2002
21	Secondary Prevention 01/2020 - 03/2005
20	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2021 - 12/2002
18	Patient Readmission 01/2021 - 09/2002